{"entities":{"Q9817":{"pageid":13978,"ns":120,"title":"Item:Q9817","lastrevid":205738,"modified":"2020-05-21T15:45:15Z","type":"item","id":"Q9817","labels":{"en":{"language":"en","value":"Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9817$B6E963A9-4F7A-4274-BA9D-6E4561836CF0","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9817$7DAF655A-19DC-4580-A1F0-AEE0B3362082","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Colnot DR","type":"string"},"datatype":"string"},"type":"statement","id":"Q9817$40822F4D-5EA8-49A4-AC48-7CB3274A28F1","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1007/s00262-003-0396-5","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9817$FFF327FF-CA8D-48F0-8847-68EEDE23E17A","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"14627130","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9817$1024C311-A048-4A92-9B61-2F5D29E022E8","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2003-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9817$B970FB7A-32C4-4302-A926-EF8F5D6F4C5B","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Cancer Immunol. Immunother.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9817$0D68C0C4-76A5-44C4-8669-35017C74C6AE","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"52","type":"string"},"datatype":"string"},"type":"statement","id":"Q9817$643E8F5C-3F43-4929-A534-EB880DE2255E","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Safety biodistribution pharmacokinetics and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9817$6222FFCA-FEBA-4B1F-BB0B-F24D74E59FD2","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"576-582","type":"string"},"datatype":"string"},"type":"statement","id":"Q9817$D5894C15-B42F-46D0-B93A-0FA07693A58F","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Colnot_DR,_et_al._Cancer_Immunol._Immunother._(2003)_cited_as_Ref_554_in_DOI:_10.1038/s41392-020-0110-5"}}}}}